The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Strategic networks

LUCC has 16 strategic translational networks based on cancer diagnosis, technology or processes. The aim of the networks is to bridge the basic and clinical science and the diverse disciplines. Networking activities include discussions about scientific challenges in the field, facilitation of new collaborations, and sharing technical and educational expertise. The key goal is to create opportunities that set the foundation for novel interdisciplinary research collaboration.

LUCC 16 translational networks (diagnosis, technology, or process-oriented):

  • Blood, lymphoma & myeloma (Anna Hagström / Stefan Scheding)
  • Brain, spinal cord & pituitary (Alexander Pietras / Johan Bengzon)
  • Breast (Sara Alkner / Lao Saal)
  • Child (Daniel Bexell / Kees-Jan Pronk)
  • Gastrointestinal - Colorectal (Pamela Buchwald / Marie-Louise Lydrup) - Hepatic-Pancreatic-Biliary (HPB) (Monika Bauden / Daniel Ansari)
  • Gynaecology (Ingrid Hedenfalk / Susanne Malander)
  • Head & neck (Malin Lindstedt / Lennart Greiff & Maria Gebre-Medhin)
  • Lung (Johan Staaf / Maria Planck)
  • Sarcoma (Karolina Leandersson Bogefors / Fredrik Mertens)
  • Skin (Göran B Jönsson / Karolin Isaksson)
  • UroCan-LUCC: Prostate-Bladder-Kidney (Håkan Axelson / Fredrik Liedberg)

Contact respective heads if you want to participate in any of the strategic translational networks.